Sam Wertheimer
Chief Investment Officer
Poliwogg Healthcare Investments

Dr. Wertheimer has long and successful experience as an investor in the healthcare and life sciences sectors. From 2000 until 2010, he was an equity partner in OrbiMed Advisors, LLC, the world's largest healthcare-dedicated investment firm, with approximately $5 billion under management. While at Orbimed, Dr. Wertheimer had primary responsibility for the management of biotechnology/medical technology focusing on venture capital funds and was responsible for the sourcing, due diligence, negotiation and management of investments. He had ten primary investments, five successful exits and brought two new products to market. He was also a Member of the OrbiMed Private Equity Investment Oversight Committee. During his tenure he raised four venture capital funds totaling $1.5 billion in committed capital. The most recent fund, Caduceus Private Investments IV, raised $550 million and closed February 2010. He was a Member of the Board of Directors of invested companies and assisted in the management of a $5 billion long/short healthcare portfolio in the pharmaceutical and biotechnology sectors.

Dr. Wertheimer received his Doctor of Philosophy degree from New York University, his Master of Public Health, with Honors from Yale University and his Bachelor of Arts from the Johns Hopkins University. He is a resident of New York City.